FPS-ZM1, a highly potent RAGE inhibitor, can penetrate the blood–brain barrier and has shown therapeutic potential in Alzheimer’s disease and Parkinson’s disease [6–8]. The gene discussed is AGER; the disease is early-onset autosomal dominant Alzheimer disease.